The price of Enveric Biosciences Inc (NASDAQ: ENVB) closed at $1.66 in the last session, up 14.48% from day before closing price of $1.45. In other words, the price has increased by $+0.2100 from its previous closing price. On the day, 13675232 shares were traded. ENVB stock price reached its highest trading level at $1.9000 during the session, while it also had its lowest trading level at $1.4517.
Ratios:
We take a closer look at ENVB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.39 and its Current Ratio is at 1.39. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 15 when PASQUALONE FRANK bought 1,000 shares for $2.14 per share. The transaction valued at 2,140 led to the insider holds 1,000 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ENVB now has a Market Capitalization of 4.55M and an Enterprise Value of -2.52M.
Stock Price History:
Over the past 52 weeks, ENVB has reached a high of $6.98, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 1.0626, while the 200-Day Moving Average is calculated to be 2.1270.
Shares Statistics:
According to the various share statistics, ENVB traded on average about 3.19M shares per day over the past 3-months and 20.49M shares per day over the past 10 days. A total of 2.74M shares are outstanding, with a floating share count of 2.27M. Insiders hold about 6.50% of the company’s shares, while institutions hold 17.86% stake in the company. Shares short for ENVB as of Feb 15, 2024 were 64.7k with a Short Ratio of 0.02, compared to 55.62k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.36% and a Short% of Float of 2.39%.
Earnings Estimates
The company has 2 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$1.54 for the current quarter, with a high estimate of -$1.5 and a low estimate of -$1.59, while EPS last year was -$2.73. The consensus estimate for the next quarter is -$1.28, with high estimates of -$1.28 and low estimates of -$1.28.
Analysts are recommending an EPS of between -$8.1 and -$8.24 for the fiscal current year, implying an average EPS of -$8.17. EPS for the following year is -$2.65, with 2 analysts recommending between -$1.87 and -$3.44.
